Transforming growth factor-α regulates subpopulation of giant cells which secrete mouse placental lactogen-I (mPL-I) and/or mPL-II at midpregnancy

Journal of Endocrinological Investigation

Volumn 19, Issue 3, 1996, Pages 146-153

  Yamaguchi, M ^a   Ogura, K ^a   Sakata, M ^a   Miyake, A ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Giant cells; Midpregnancy; mPL I; mPL II; TGF

Indexed keywords

CELL PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR; PLACENTA LACTOGEN; TRANSFORMING GROWTH FACTOR ALPHA; TRICHLOROACETIC ACID;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL SUBPOPULATION; CELL VIABILITY; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; FEMALE; GENE EXPRESSION REGULATION; GIANT CELL; HEMOLYTIC PLAQUE ASSAY; HORMONE RELEASE; IMMUNOCYTOCHEMISTRY; IMMUNOPRECIPITATION; IN SITU HYBRIDIZATION; MOUSE; NONHUMAN; PREGNANCY; PROTEIN SYNTHESIS; TRANSCRIPTION REGULATION;

EID: 0029946629     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03349857     Document Type: Article

References (23)

1. Yamaguchi M., Endo H., Thordarson G., Ogren L., Talamantes F. Modulation of mouse placental lactogen-I secretion in vitro: Effects of progesterone and mouse placental lactogen-II. Endocrinology 130: 2897, 1992.
2. Yamaguchi M., Ogren L., Endo H., Thordarson G., Kensinger R., Talamantes F. Epidermal growth factor stimulates mouse placental lactogen-I but inhibits mouse placental lactogen-II secretion in vitro. Proc. Natl. Acad. Sci. USA A89: 11396, 1992.
3. Yamaguchi M., Ogren L., Kurachi H., Hirota K., Imai T., Talamantes F. Opposite effects of transforming growth factor-α and epidermal growth factor on mouse placental lactogen-l secretion. Proc. Natl. Acad. Sci. USA 92: 2830, 1995.
4. Yamaguchi M., Imai T., Maeda T., Sakata M., Miyake A. Cyclic adenosine-3′.5′-monophosphate stimulates mouse placental lactogen-I (mPL-L) secretion but inhibits mPL-II secretion at midpregnancy. Endocrinology 136: 1388, 1995.
5. Yamaguchi M., Ogren L, Southard J.N., Kurachi H., Miyake A., Talamantes F. Interleukin-6 inhibits mouse placental lactogen II but not mouse placental lactogen-I secretion in vitro. Proc. Natl. Acad. Sci. USA 90: 11905, 1993.
6. Yamaguchi M., Ogren L., Barnard R., Sawada T., Miyake A., Talamantes F. Selective inhibition of mouse placental lactogen II secretion by tumor necrosis factor-α J. Endocrinol. 143:95, 1994.
7. Yamaguchi M., Kurachi H., Tadokoro C., Sakata M., Yoshimoto Y., Masumoto N., Tasaka K., Miyake A. Tumor necrosis factor-α (TNF-a) inhibits expression of mouse placental lactogen-II through TNF-α type-I but not type-II receptor. Biochem. Biophys. Res. Commun. 202: 1599, 1994.
8. Yamaguchi M., Imai T., Maeda T., Sakata M., Miyake A., Linzer D.I.H. Cyclic adenosine 3′,5′-monophosphate stimulation of placental proliferin and proliferin-related protein secretion. Endocrinology 136: 2040, 1995.
9. Yamaguchi M., Ogren L., Endo H., Thordarson G., Bigsby R.M., Talamantes F. Production of mouse placental lactogen-I and placental lactogen-II by the same giant cell. Endocrinology 131: 1595, 1992.
10. Yamaguchi M., Ogren L., Endo H., Soares M.J., Talamantes F. Co-localization of placental lactogen-I, placental lactogen-II, and proliferin in the mouse placenta at midpregnancy. Biol. Reprod. 51: 1188, 1994.
11. Wilcox J.N., Derynck R. Developmental expression of transforming growth factors alpha and beta in mouse fetus. Mol. Cell. Biol. 3:3415, 1988.
12. Stern P.M., Krieger H.S., Nissenson R.A., Williams R.D., Winkler M.E., Derynck R., Strewler G.J. Human transforming growth factor-alpha stimulates bone resorption in vitro. J. Clin. Invest. 76:2016, 1985.
13. Ibbotson K.J., Harrod J., Gowen M., D'Souza S., Smith D.D., Winkler M.E., Derynck R., Mundy G.R. Human transforming growth factor α stimulates bone resorption and inhibits formation in vitro. Proc. Natl. Acad. Sci. USA 83: 22281, 1986.
14. Schreiber A.B., Winkler M.E., Derynck R. Transforming growth factor-α: A more potent angiogenic mediator than epidermal growth factor. Science 232: 1250, 1986.
15. Gan B.S., Hollenberg M.D., MacCannell K.L., Lederis K., Winkler M.E., Derynck R. Distinct vascular actions of epidermal growth factor-urogastrone and transforming growth factor-α. J. Pharmacol. Exp. Ther. 242: 331, 1987.
16. Korc M., Haussler C.A., Trookman N.S. Divergent effects of epidermal growth factor and transforming growth factors on a human endometrial carcinoma cell line. Cancer Res. 47: 4909, 1987.
17. Siegfried J.M. Detection of human lung epithelial cell growth factors produced by a lung carcinoma cell line: Use in culture of primary solid lung tumors. Cancer Res. 47: 2903, 1987.
18. Ristimaki A. Transforming growth factor α stimulates prostacyhn production by cultured human vascular endothelial cells more potently than epidermal growth factor. Biochem. Biophys. Res. Commun. 160: 1100, 1989.
19. Ogren L., Southard J.N., Colosi P.. Linzer D.I.H., Talamantes F. Mouse placental lactogen-I: RIA and gestational profile in maternal serum. Endocrinology 125: 2253, 1989.
20. Soares M.J., Colosi P., Talamantes F. The development and characterization of a homologous radioimmunoassay for mouse placental lactogen. Endocrinology 110: 668, 1982.
21. Basch C.V., Talamantes F. In vitro kinetics of synthesis and release of mouse placental lactogen. Endocrinology 119: 1939, 1986.
22. Scarbrough K., Weiland N.G., Larson G.H., Sortino M.A., Chiu S., Hirshfield A.N., Wise P.M. Measurement of peptide secretion and gene expression in the same cell. Mol. Endocrinol. 5:134, 1991.
23. Faria T.N., Ogren L., Talamantes F., Linzer D.I.H., Soares M.J. Localization of placental lactogen-I in trophoblast giant cells of the mouse placenta. Biol. Reprod. 44: 327, 1991.